Hall Ashley (CIK 0001801842)

Latest company ownership

Role: Chief Development Officer
Shares held
112,317
Last filed at
Sep 22, 2025
Confidence Score
45.5
2025Q4
Confidence Score History
2025Q3 2025Q4
Role: Chief Development Officer
Shares held
15,625
Last filed at
Aug 29, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 18, 2025 Sep 22, 2025 Structure Therapeutics Inc. Chief Development Officer Sell 26.3 -6,021 -5.09% $46.6K
Aug 28, 2023 Aug 29, 2023 OnKure Therapeutics, Inc. Chief Development Officer Sell 22.5 -15,625 -28.29% $98.1K